文献速递肾移植

慢性肾脏病尿液蛋白质组学预测因子CKD273与肾移植受者移植物衰竭临床风险因素的关联

Association of the chronic kidney disease urinary proteomic predictor CKD273 with clinical risk factors of graft failure in kidney allograft recipients.
PubMed 文献 · Nephrol Dial Transplant · 2022-01-01

结果显示CKD273与血清肌酐各时间点显著相关,预测未来6年移植物丢失的AUC为0.89,优于Nankivell eGFR的0.67;CKD273阳性者移植物丢失风险比高达16.5,提示其可用于移植物丢失风险分层。

要点

  • CKD273与移植后各时间点血清肌酐显著相关,并与Nankivell eGFR斜率呈中度负相关(r=-0.29,P=0.05)。
  • CKD273预测未来6年移植物丢失和死亡的AUC为0.89,优于Nankivell eGFR的0.67。
  • CKD273阳性患者移植物丢失的风险比为16.5,可用于风险分层。

核心结论

  • 在随访8年的活体供肾移植受者队列中,CKD273对移植物丢失具有显著的风险分层价值。
  • 本研究为CKD273作为长期移植物功能风险分层的预后工具提供了概念基础,有待大型前瞻性临床试验进一步评估。

研究设计与样本

  • 所有患者在移植后3、6、12、24、36、48和96个月接受临床检查及常规实验室筛查,包括肌酐、尿素、白蛋白和24小时蛋白尿。
  • 移植物功能按Nankivell公式估算;术后24个月尿样经毛细管电泳耦合质谱分析,并用慢性肾脏病分类器CKD273分类。

主要发现

  • CKD273与各时间点血清肌酐显著相关。
  • CKD273与Nankivell eGFR斜率呈中度负相关(r=-0.29,P=0.05)。
  • 蛋白质组学分析后未来6年移植物丢失和死亡的ROC分析AUC:CKD273为0.89,Nankivell eGFR为0.67。
  • 按CKD273阳性与阴性分组,CKD273阳性者移植物丢失的风险比为16.5。

临床怎么用

  • 对于活体供肾移植受者,术后24个月可考虑检测尿液CKD273以辅助移植物丢失风险分层。
  • CKD273阳性提示移植物丢失风险显著升高,可加强随访监测。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Kidney transplantation is the best treatment option for end-stage kidney disease but is still associated with long-term graft failure. In this study, we evaluated the application of urinary proteomics to identify grafts with high failure risk before initial decline of estimated glomerular filtration rate (eGFR) with irreversible graft changes. METHODS: Fifty-two living donor kidney transplant recipients (KTR) with 8-year follow-up were enrolled. All patients underwent clinical examination and had a routine laboratory screening at 3, 6, 12, 24, 36, 48 and 96 months post-transplantation, including creatinine, urea, albumin and 24-h proteinuria. Graft function was estimated according to Nankivell. Urine samples at Month 24 were analysed by capillary electrophoresis coupled mass spectrometry followed by classification with the chronic kidney disease classifier CKD273. RESULTS: CKD273 showed significant correlation with serum creatinine at every time point and moderate inverse correlation for the slope in glomerular filtration rates by Nankivell (r = -0.29, P = 0.05). Receiver operating characteristics analysis for graft loss and death within the next 6 years after proteomic analysis resulted in an area under curve value of 0.89 for CKD273 being superior to 0.67 for Nankivell eGFR. Stratification into CKD273-positive and -negative patient groups revealed a hazard ratio of 16.5 for prevalence of graft loss in case of CKD273 positivity. CONCLUSIONS: Using a representative KTR cohort with 8-year follow-up, we could demonstrate significant value of CKD273 for risk stratification of graft loss. This study provides the conceptual basis for further evaluation of CKD273 as a prognostic tool for long-term graft function risk stratification by large prospective clinical trials.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Rambabova-Bushljetik I, Metzger J, Siwy J, et al. Association of the chronic kidney disease urinary proteomic predictor CKD273 with clinical risk factors of graft failure in kidney allograft recipients. Nephrol Dial Transplant. 2022. PMID: 34634117. doi:10.1093/ndt/gfab297

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。